v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2024   168.6      
Balance at beginning of period at Dec. 31, 2024   $ 1,942 $ (2,539) $ 2,300 $ 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings       430 2
Other comprehensive income (loss)     39    
Issuance of common stock and stock options exercised (in shares)   0.7      
Issuance of common stock and stock options exercised   $ (90)      
Share repurchase program (in shares)   (0.7)      
Share repurchase program       (325)  
Share-based compensation expenses   $ 66      
Dividends declared       (182)  
Balance at ending of period (in shares) at Mar. 29, 2025   168.6      
Balance at end of period at Mar. 29, 2025   $ 1,918 (2,500) 2,223 18
Balance at beginning of period (in shares) at Dec. 31, 2024   168.6      
Balance at beginning of period at Dec. 31, 2024   $ 1,942 (2,539) 2,300 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings $ 1,510        
Other comprehensive income (loss) 122        
Balance at ending of period (in shares) at Sep. 27, 2025   168.4      
Balance at end of period at Sep. 27, 2025   $ 2,150 (2,417) 2,594 17
Balance at beginning of period (in shares) at Mar. 29, 2025   168.6      
Balance at beginning of period at Mar. 29, 2025   $ 1,918 (2,500) 2,223 18
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings       513 2
Other comprehensive income (loss)     88    
Issuance of common stock and stock options exercised (in shares)   0.3      
Issuance of common stock and stock options exercised   $ 53      
Share repurchase program (in shares)   (0.6)      
Share repurchase program       (219)  
Share-based compensation expenses   $ 74      
Dividends declared       (182)  
Dividends paid to non-controlling interest on subsidiary common stock         (4)
Balance at ending of period (in shares) at Jun. 28, 2025   168.3      
Balance at end of period at Jun. 28, 2025   $ 2,045 (2,412) 2,335 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 564     562 2
Other comprehensive income (loss) (5)   (5)    
Issuance of common stock and stock options exercised (in shares)   0.4      
Issuance of common stock and stock options exercised   $ 32      
Share repurchase program (in shares)   (0.3)      
Share repurchase program       (121)  
Share-based compensation expenses   $ 73      
Dividends declared       (182)  
Dividends paid to non-controlling interest on subsidiary common stock         (1)
Balance at ending of period (in shares) at Sep. 27, 2025   168.4      
Balance at end of period at Sep. 27, 2025   $ 2,150 (2,417) 2,594 17
Balance at beginning of period (in shares) at Dec. 31, 2025   167.4      
Balance at beginning of period at Dec. 31, 2025 2,427 $ 2,281 (2,420) 2,549 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings       366 2
Other comprehensive income (loss)     (3)    
Issuance of common stock and stock options exercised (in shares)   1.0      
Issuance of common stock and stock options exercised   $ (8)      
Share repurchase program (in shares)   (0.3)      
Share repurchase program       (118)  
Share-based compensation expenses   $ 98      
Dividends declared       (201)  
Balance at ending of period (in shares) at Apr. 04, 2026   168.1      
Balance at end of period at Apr. 04, 2026   $ 2,371 (2,423) 2,596 19
Balance at beginning of period (in shares) at Dec. 31, 2025   167.4      
Balance at beginning of period at Dec. 31, 2025 2,427 $ 2,281 (2,420) 2,549 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 1,440        
Other comprehensive income (loss) $ 13        
Share repurchase program (in shares) (1.3)        
Share repurchase program $ (538)        
Balance at ending of period (in shares) at Oct. 03, 2026   167.4      
Balance at end of period at Oct. 03, 2026 3,086 $ 2,632 (2,407) 2,844 17
Balance at beginning of period (in shares) at Apr. 04, 2026   168.1      
Balance at beginning of period at Apr. 04, 2026   $ 2,371 (2,423) 2,596 19
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings       557 1
Other comprehensive income (loss)     (2)    
Issuance of common stock and stock options exercised (in shares)   0.1      
Issuance of common stock and stock options exercised   $ (2)      
Share repurchase program (in shares)   (0.8)      
Share repurchase program       (326)  
Share-based compensation expenses   $ 101      
Dividends declared       (200)  
Dividends paid to non-controlling interest on subsidiary common stock         (4)
Balance at ending of period (in shares) at Jul. 04, 2026   167.4      
Balance at end of period at Jul. 04, 2026   $ 2,470 (2,425) 2,627 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 514     512 2
Other comprehensive income (loss) $ 18   18    
Issuance of common stock and stock options exercised (in shares)   0.2      
Issuance of common stock and stock options exercised   $ 59      
Share repurchase program (in shares) (0.2) (0.2)      
Share repurchase program $ (94)   (94)  
Share-based compensation expenses   $ 103      
Dividends declared       (201)  
Dividends paid to non-controlling interest on subsidiary common stock         (1)
Balance at ending of period (in shares) at Oct. 03, 2026   167.4      
Balance at end of period at Oct. 03, 2026 $ 3,086 $ 2,632 $ (2,407) $ 2,844 $ 17